AzTrials
AzTrials

Smoking CessationNCT03042650

Intensive Referral to Reduce Smoking in Probationers

A study testing Intensive Referral Intervention Group and Standard Practice Facilitated Group in people with Smoking Cessation and Substance Use Disorder, run by University of Nebraska at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine if Intensive Referral Intervention increases motivation to quit cigarette smoking and quitting-related behaviors in probationers and also to determine if Intensive Referral Intervention improves short-term substance use outcomes in probationers with substance use disorder. Read more about this study

Who is it for?
Ages 19 years and older
Conditions the study is for
Smoking Cessation, Substance Use Disorder
What is being tested?
Intensive Referral Intervention Group and Standard Practice Facilitated Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 siteUnited States
Study dates
1 Jul 2016to 27 Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • CBR-MH Probationers in Douglas County, NE
  • SUD
  • daily cigarette smoker

Who cannot join

  • Under guardianship
  • unwilling to provide personal contact information
  • unable to pass Mini-Cog

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Unversity of Nebraska Medical Center

    Omaha, Nebraska, 68198

Other trials in United States

About this study

The purpose of this study is to determine if Intensive Referral Intervention increases motivation to quit cigarette smoking and quitting-related behaviors in probationers and also to determine if Intensive Referral Intervention improves short-term substance use outcomes in probationers with substance use disorder.

Read the detailed description

This is a longitudinal study of adults on probation who have a Substance Use Disorder (SUD) and smoke cigarettes. One-half of probation officers will be trained in the Intensive Referral Intervention (IRI) while one-half will deliver Standard Practice which is to encourage support group attendance. Research staff will assess fidelity to the IRI in trained probation officers. The investigators propose to enroll 150 probationers over a four month period and complete 3 and 6-month follow-up interviews to assess smoking and substance use measures.

Being tested
Intensive Referral Intervention Group, Standard Practice Facilitated Group
Medical subject headings
Smoking Cessation, Substance-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intensive Referral Intervention GroupBehavioural

    The Intensive Referral Intervention Group will review a series of pamphlets regarding participation in 12-step meetings as well as smoking cessation that will be presented in a group setting to probationers in 3 sessions.

  • Standard Practice Facilitated GroupBehavioural

    The Standard Practice Facilitated Group will receive 3 sessions of the current standard practice for facilitated groups.

Study groups in NCT03042650
Study groupRoleWhat they receive
Intensive Referral Intervention GroupExperimentalIntensive Referral Intervention will by done by trained probation officers
Receives: Behavioral: Intensive Referral Intervention Group
Standard Practice Facilitated GroupActive comparatorStandard Current Practice will be provided by untrained probation officers
Receives: Behavioral: Standard Practice Facilitated Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motivation measured by Fagerstrom Test

    Increased Motivation to quit cigarette smoking in probationers as indicated by change in Fagerstrom Test for Nicotine Dependence

    Measured: 6 Months

Secondary outcomes (1)
  1. Change in Timeline Follow-back Calendar

    Improved short term substance use outcomes as indicated by change in Timeline Follow-back Calendar

    Measured: 6 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2017 (estimated)
  2. Study start1 Jul 2016
  3. Primary completion27 Sep 2019
  4. Study completion27 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03042650
Sponsor's protocol ID
0018-16-FB
Status last verified
Sep 2023
First submitted
29 Dec 2016
Last updated
29 Sep 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Intensive Referral Intervention Group and Standard Practice Facilitated Group in people with Smoking Cessation and Substance Use Disorder, run by University of Nebraska at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motivation measured by Fagerstrom Test (time frame: 6 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in